http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM#head
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://www.nanopub.org/nschema#hasAssertion
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM#assertion
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://www.nanopub.org/nschema#hasProvenance
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM#provenance
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://www.nanopub.org/nschema#hasPublicationInfo
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM#assertion
http://rdf.disgenet.org/resource/gda/DGNc07aab5c623ebb01ad92fddf5bfb404a
http://semanticscience.org/resource/SIO_000628
http://identifiers.org/ncbigene/3845
http://rdf.disgenet.org/resource/gda/DGNc07aab5c623ebb01ad92fddf5bfb404a
http://semanticscience.org/resource/SIO_000628
http://linkedlifedata.com/resource/umls/id/C0009402
http://rdf.disgenet.org/resource/gda/DGNc07aab5c623ebb01ad92fddf5bfb404a
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://semanticscience.org/resource/SIO_001122
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM#provenance
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM#assertion
http://purl.org/dc/terms/description
[Patients with metastatic or locally recurrent CRC who had previously received 5-flurouracil (5-FU), oxaliplatin, and irinotecan were assigned to receive EZN-2208 monotherapy (9 mg/m(2) on days 1, 8, and 15 every 28 days for patients with KRAS-mutant tumors only [arm A]), and patients with KRAS wild-type tumors were randomized (2:1) to receive either EZN-2208 plus cetuximab (400 mg/m(2) loading dose on day 1 followed by 250 mg/m(2) weekly starting on day 8 [arm B]) or irinotecan 125 mg/m(2) on days 1 and 8 every 21 days plus cetuximab at the same doses indicated above (arm C).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM#assertion
http://purl.org/ontology/wi/core#evidence
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM#assertion
http://semanticscience.org/resource/SIO_000772
http://identifiers.org/pubmed/24105075
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
http://purl.obolibrary.org/obo/ECO_0000203
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://purl.org/pav/importedOn
2017-02-19
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.obolibrary.org/obo/ECO_0000212
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#comment
Gene-disease associations inferred from text-mining the literature.
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#label
DisGeNET evidence - LITERATURE
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://purl.org/dc/terms/created
2017-10-17T13:14:11+02:00
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://purl.org/dc/terms/rights
http://opendatacommons.org/licenses/odbl/1.0/
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://purl.org/dc/terms/rightsHolder
http://rdf.disgenet.org/v5.0.0/void/IBIGroup
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://purl.org/dc/terms/subject
http://semanticscience.org/resource/SIO_000983
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://purl.org/net/provenance/ns#usedData
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://purl.org/pav/authoredBy
http://orcid.org/0000-0001-5999-6269
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-7534-7661
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-9383-528X
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-1244-7654
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://purl.org/pav/createdBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP628334.RA3R47oAxluWfsJXR-Fpt-tufWCpgKAO7zQiuc0SrOIrM
http://purl.org/pav/version
v5.0.0.0
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://purl.org/pav/version
v5.0.0